CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced the launch of a new program specifically geared towards using ...
Group testing algorithms are an emerging frontier in applied mathematics and computer science that focus on the efficient identification of defective items within large populations through pooled ...
Flow cytometry–triggered genomic testing and automation reduced turnaround times for AML diagnostics, enhancing personalized therapy and patient care. The initiative involved clinician education, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results